Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enamel Matrix Proteins for Intrabony Defects in Periodontitis
NCT03025204Phase 4Completed
- Sponsor
- Universidade Estadual de Campinas
- Start
- Feb 2016
- Primary completion
- Apr 2018
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 4 trial of enamel matrix derivative in Aggressive Periodontitis (AP), chronic periodontitis, sponsored by Universidade Estadual de Campinas. Started Feb 2016; status: completed.
02
Drugs
enamel matrix derivative
03
Conditions
Aggressive Periodontitis (AP)chronic periodontitis
Beyond the preview
Go deeper on NCT03025204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03025204.